Authors



Sigrid Mohnen, PhD

Latest:

Bundled Payments for Diabetes Care and Healthcare Costs Growth: A 2-Year Follow-up Study

Disease management programs for diabetes care based on bundled payment did not slow down the cost growth. Multimorbid adult patients with diabetes had largest cost growth.



Joshua P. Metlay, MD, PhD

Latest:

Unintended Consequences of a Quality Measure for Acute Bronchitis

A quality measure reduced antibiotic use for patients with acute bronchitis but led to use of an alternative diagnosis, offsetting most of the observed improvement.




Emily Allinder Scott, MHA

Latest:

Improving Population Health Through Multistakeholder Partnerships

Improving population health requires developing innovative multistakeholder partnerships to enable mining and cross-leveraging data sets, creating patient touchpoint “ecosystems,” and aligning investments with each stakeholder’s returns.


Michael A. Horberg, MD

Latest:

Patient Experience After Modifying Visit Delivery During the COVID-19 Pandemic

Coronavirus disease 2019 (COVID-19) was associated with immediate weekly visit trend decreases for overall, primary care, and specialty care with long-term recovery trends; transformation to virtual visits; and increasing long-term trends for meeting patient scheduling and visit needs.


Timothy J. Day, MSPH

Latest:

Patient Experience During a Large Primary Care Practice Transformation Initiative

Four years of practice transformation toward comprehensive primary care had little effect on patient experience.



Amal Trivedi, MD

Latest:

Medicare Advantage Control of Postacute Costs: Perspectives From Stakeholders

This qualitative study examines the methods that Medicare Advantage plans use to control or reduce postacute spending and their associated unintended consequences.


Arthur J. Davidson, MD, MSPH

Latest:

Care by Cell Phone: Text Messaging for Chronic Disease Management

Cell phone“based text messaging may be used to feasibly support chronic disease management and engagement in diabetes self-care behaviors for some patients.



Peter W. Crooks, MD

Latest:

Clinical Outcomes and Healthcare Use Associated With Optimal ESRD Starts

Optimal end-stage renal disease (ESRD) starts were associated with lower 12-month morbidity, mortality, and inpatient and outpatient utilization in an integrated healthcare delivery system.



value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspective. [published online April 3, 2018]. J Med Econ. doi: 10.1080/13696998.2018.1457533.

Latest:

Study Summary: Estimating the Value-Based Price Range of Erenumab for Migraine Prevention

This health economic analysis predicted that, compared with use of supportive care, erenumab treatment will reduce the direct and indirect costs associated with migraine and increase quality-adjusted life-years for patients who have previously experienced treatment failure with at least 1 preventive migraine treatment.



Eric Stewart, MD

Latest:

Collaborative Care Plans Reduce Subspecialty Consults: The Experience From a Safety Net Hospital

Collaborative care plans combined with provider education resulted in significant reductions in referrals to specialists without an apparent increase in the rate of emergency department visits or hospital admissions.


Jeffrey M. Ashburner, PhD, MPH

Latest:

Chronic Disease Outcomes From Primary Care Population Health Program Implementation

Patients in practices with central population health coordinators had greater improvement in short-term chronic disease outcome measures compared with patients in practices without central support.


Nancee V. Waterbury, PharmD, BCACP

Latest:

Adding Glucose-Lowering Agents Delays Insulin Initiation and Prolongs Hyperglycemia

A review of national Veterans Health Administration data has identified how the number of glucose-lowering agents used prior to insulin initiation impacts glycemic control.


Debra A. Wolff, MS

Latest:

Variation in the Cost of Medications for the Treatment of Colorectal Cancer

Using data from a nationwide registry, this study revealed significant variation in the use and cost of contemporary regimens for colorectal cancer.




Dave Nellesen, PhD

Latest:

Reimbursement Landscape for Molecular Testing in Non-Small Cell Lung Cancer

This review assesses the current molecular testing landscape for non–small-cell lung cancer in the United States.


Ellen Scherl, MD

Latest:

Inflammatory Bowel Disease Readmissions Are Associated With Utilization and Comorbidity

Thirty-day readmissions related to inflammatory bowel disease are common and associated with longer length of stay and a higher likelihood of having an associated comorbid condition compared with index hospitalizations.


Charles Maynard, PhD

Latest:

Assessing the Effect of the VHA PCMH Model on Utilization Patterns Among Veterans With PTSD

This study utilizes a validated instrument to create case and control groups to measure the effect of the Veterans Health Administration (VHA)’s patient-centered medical home (PCMH) model on utilization patterns among veterans with posttraumatic stress disorder (PTSD).


Daniel J. Elliott, MD, MSCE

Latest:

Impact of Care Coordination Based on Insurance and Zip Code

A care transitions program for patients who underwent percutaneous coronary intervention appeared to reduce 30-day rehospitalizations for patients with Medicaid who lived in wealthier zip codes.




Vartan Tashjian, BS

Latest:

Preventing Patient Absenteeism: Validation of a Predictive Overbooking Model

Electronic health record data can be used to predict patient absenteeism accurately. Predictive overbooking of missed appointments can significantly increase service utilization.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo